Zoetis | ZTS - Equity Capital And Reserves


Zoetis reported $3.15B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -5.94B 721M Jun/2026
Align Technology USD 4.23B 83.03M Jun/2026
Bayer EUR 28.85B 2.9B Mar/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Coherus Biosciences USD 60.84M 17.78M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Eli Lilly USD 33.88B 2.68B Jun/2026
Henry Schein USD 3.16B 109M Jun/2026
Idexx Laboratories USD 1.61B 56.47M Jun/2026
Illumina USD 2.84B 162M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Laboratory Of America USD 8.61B 121.8M Jun/2026
Merck USD 41.93B 3.94B Jun/2026
Neogen USD 2.09B 9.5M Mar/2026
Pacira USD 671.98M 18.08M Jun/2026
Perrigo USD 2.52B 17M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Quest Diagnostics USD 7.52B 150M Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
Sanofi EUR 73.14B 1.43B Mar/2026
Zoetis USD 3.15B 85M Jun/2026